You should not be treated if you:

Are pregnant or breastfeeding, as the safety of these products for use during pregnancy, or in women who are breastfeeding, has not been studied.

Have a history of hypertrophic scarring or keloid formation.

Have evidence of scars at the intended treatment sites.

Have acne and / or other inflammatory diseases of the skin, such as rosacea, seborrheic dermatitis, and psoriasis.

Have allergic history including: severe allergic reactions (anaphylaxis), heightened immune responses to common allergens, especially inhaled allergens and food allergens (atopy), allergy to hyaluronic acid products, allergy to lidocaine, Streptococcal proteins or have plans to undergo administration of graded doses of allergens (desensitization therapy) during treatment with Revanesse®.

Have acute or chronic skin disease, such as seborrheic dermatitis or rosacea, in or near the injection sites, or any infection or unhealed wound of the face.

Are under concomitant anticoagulant therapy, antiplatelet therapy (aspirin or plavix), or have a history of bleeding disorders, clotting disorders such as hemophilia or connective tissue disorders such as systemic lupus erythematosus.

If you are under the age of 22 you should not be treated with a Revanesse® dermal filler.

It’s not recommended to use Revanesse® dermal fillers in conjunction with a laser, intense pulsed light, chemical peeling or dermabrasion treatments, or with Over-the-counter (OTC) wrinkle products or prescription wrinkle treatments within 4 weeks prior to treatment, as there is a possible risk of inflammation or infection at the treatment site.